UncategorizedTelomir reports new preclinical data: Telomir-1 reduces PSA in prostate cancer cells – Longevity.Technology Empower Meds / November 26, 2025
UncategorizedC2N Diagnostics permitted to offer Alzheimer’s blood tests in New York State – Longevity.Technology Empower Meds / November 26, 2025
UncategorizedRegenerative macrophage therapy demonstrates potential in liver disease Empower Meds / November 26, 2025
UncategorizedBiomarkers of Aging Consortium fosters innovation and translation Empower Meds / November 26, 2025
UncategorizedInsilico announces positive topline results for IPF treatment Empower Meds / November 26, 2025
UncategorizedNew VR tool targets early detection of cognitive impairment Empower Meds / November 26, 2025
UncategorizedAI drug discovery firm inks investment and collaboration deal with NVIDIA Empower Meds / November 26, 2025
UncategorizedFountain Life adds concierge care services to apex premium longevity membership – Longevity.Technology Empower Meds / November 26, 2025
UncategorizedOneSkin secures $20 million to advance skin health solutions Empower Meds / November 26, 2025
